Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate.
Triamcinolone was granted FDA approval on 3 December 1957. In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval - for the treatment of patients with macular edema associated with uveitis.
肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱,故一般不用作肾上腺皮质功能减退的替代治疗。
Phramongkutklao Hospital, Bangkok, Thailand
Alabama Orthopaedic Center- Research, Vestavia Hills, Alabama, United States
Onyx Clinical Research, Surprise, Arizona, United States
Tucson Orthopaedic Institute (TOI) - East Office, Tucson, Arizona, United States
Stony Brook Orthopaedics, Stony Brook, New York, United States
Assiut University, Assiut, Egypt
Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare, New taipei city, Zhonghe Dist, Taiwan
Health Science University Haydarpasa Numune Research and Training Hospital, Istanbul, Uskudar, Turkey
Chu Reims, Reims, France
Center For Dermatology Clinical Research, Inc, Fremont, California, United States
Al-Azhar University, Assiut, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.